Biotech Values

[Double_Bagel]

If MNTA gets the PI against Amphastar and Teva doesn't get approved for a while, then shouldn't we take the 45% profit share / royalty hybrid arrangement seriously?

But worst of all, how can anyone take the 45% profit share seriously once you know that the hybrid split was triggered by the AG AND we can reasonably expect an Amphastar launch (or a TEVA launch) which would reduce the payments to a straight royalty.